The use of streptolysin O (SLO) as an adjunct therapy for Rhodococcus equi pneumonia in foals

Veterinary Microbiology

Volumn 154, Issue 1-2, 2011, Pages 156-162

  Horohov, David W ^a   Loynachan, Alan T ^a   Page, Allen E ^a   Hughes, Katherine ^a   Timoney, John F ^a   Fettinger, Michael ^a   Hatch, Thomas ^b   Spaulding, James G ^c   McMichael, John ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Milkhaus Veterinary Products Inc   (United States)

^c LOUISIANA TECH UNIVERSITY   (United States)

Author keywords

Adjunct therapy; Foal; Rhodococcus equi; Streptolysin O

Indexed keywords

CLARITHROMYCIN; RIFAMPICIN; STREPTOLYSIN O;

ADJUVANT THERAPY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COUNT; BACTERIAL PNEUMONIA; CONTROLLED STUDY; DISEASE SEVERITY; FOAL; HISTOCHEMISTRY; HISTOPATHOLOGY; NONHUMAN; RHODOCOCCUS EQUI; RHODOCOCCUS EQUI PNEUMONIA; SURVIVAL TIME; TREATMENT RESPONSE;

ACTINOMYCETALES INFECTIONS; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; FIBRINOGEN; HORSE DISEASES; HORSES; LUNG; MACROLIDES; PNEUMONIA, BACTERIAL; RHODOCOCCUS EQUI; RIFAMPIN; STREPTOLYSINS;

BACTERIA (MICROORGANISMS); EQUIDAE; RHODOCOCCUS EQUI;

EID: 80655144367     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2011.06.037     Document Type: Article

References (28)

1. Ainsworth D.M., Eicker S.W., Yeagar A.E., Sweeney C.R., Viel L., Tesarowski D., Lavoie J.P., Hoffman A., Paradis M.R., Reed S.M., Erb H.N., Davidow E., Nalevanko M. Associations between physical examination, laboratory, and radiographic findings and outcome and subsequent racing performance of foals with Rhodococcus equi infection: 115 cases (1984-1992). J. Am. Vet. Med. Assoc. 1998, 213:510-515.
2. Bansal S., Chhibber S. Curcumin alone and in combination with augmentin protects against pulmonary inflammation and acute lung injury generated during Klebsiella pneumoniae B5055-induced lung infection in BALB/c mice. J. Med. Microbiol. 2010, 59:429-437.
3. Bhakdi S., Bayley H., Valeva A., Walev I., Walker B., Weller U., Kehoe M., Palmer M. Staphylococcal alpha-toxin, streptolysin-O, and Escherichia coli hemolysin: prototypes of pore-forming bacterial cytolysins. Arch. Microbiol. 1996, 165:73-79.
4. Bowles P.M., Woolcock J.B., Mutimer M.D. Early events associated with experimental infection of the murine lung with Rhodococcus equi. J. Comp. Pathol. 1989, 101:411-420.
5. Fernanandez-Garayzabal J.F., Delgado C., Blanco M.M., Suarez G., Dominguez L. Cholesterol oxidase from Rhodococcus equi is likely the major factor involved in the cooperative lytic process (CAMP reaction) with Listeria monocytogenes. Lett. Appl. Microbiol. 1996, 22:249-252.
6. Giguere S., Jacks S., Roberts G.D., Hernandez J., Long M.T., Ellis C. Retrospective comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with Rhodococcus equi pneumonia. J. Vet. Intern. Med. 2004, 18:568-573.
7. Giguere S., Lee E., Williams E., Cohen N.D., Chaffin M.K., Halbert N., Martens R.J., Franklin R.P., Clark C.C., Slovis N.M. Determination of the prevalence of antimicrobial resistance to macrolide antimicrobials or rifampin in Rhodococcus equi isolates and treatment outcome in foals infected with antimicrobial-resistant isolates of R. equi. J. Am. Vet. Med. Assoc. 2010, 237:74-81.
8. Giguere S., Prescott J.F. Clinical manifestations, diagnosis, treatment, and prevention of Rhodococcus equi infections in foals. Vet. Microbiol. 1997, 56:313-334.
9. Giguere S., Wilkie B.N., Prescott J.F. Modulation of cytokine response of pneumonic foals by virulent Rhodococcus equi. Infect. Immun. 1999, 67:5041-5047.
10. Gonzalez-Avila G., Sandoval C., Herrera M.T., Ruiz V., Sommer B., Sada E., Ramos C., Sarabia M.C. Mycobacterium tuberculosis effects on fibroblast collagen metabolism. Respiration 2009, 77:195-202.
11. Halbur P.G., Paul P.S., Meng X.J., Lum M.A., Andrews J.J., Rathje J.A. Comparative pathogenicity of nine US porcine reproductive and respiratory syndrome virus (PRRSV) isolates in a five-week-old cesarean-derived, colostrum-deprived pig model. J. Vet. Diagn. Invest. 1996, 8:11-20.
12. Hines S.A., Stone D.M., Hines M.T., Alperin D.C., Knowles D.P., Norton L.K., Hamilton M.J., Davis W.C., McGuire T.C. Clearance of virulent but not avirulent Rhodococcus equi from the lungs of adult horses is associated with intracytoplasmic gamma interferon production by CD4+ and CD8+ T lymphocytes. Clin. Diagn. Lab. Immunol. 2003, 10:208-215.
13. Junqueira L.C., Bignolas G., Brentani R.R. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem. J. 1979, 11:447-455.
14. Lakritz J., Wilson W.D., Berry C.R., Schrenzel M.D., Carlson G.P., Madigan J.E. Bronchointerstitial pneumonia and respiratory distress in young horses: clinical, clinicopathologic, radiographic, and pathological findings in 23 cases (1984-1989). J. Vet. Intern. Med. 1993, 7:277-288.
15. Linder R., Bernheimer A.W. Oxidation of macrophage membrane cholesterol by intracellular Rhodococcus equi. Vet. Microbiol. 1997, 56:269-276.
16. Martens R.J., Martens J.G., Fiske R.A., Hietala S.K. Rhodococcus equi foal pneumonia: protective effects of immune plasma in experimentally infected foals. Equine Vet. J. 1989, 21:249-255.
17. Naruse K., Quan Y.S., Kim B.C., Choi S.M., Park C.S., Jin D.I. Streptolysin-o treatment of fetal fibroblasts improves cell fusion and in vitro development of porcine nuclear transfer embryos. J. Reprod. Dev. 2009, 55:236-239.
18. Pei Y., Dupont C., Sydor T., Haas A., Prescott J.F. Cholesterol oxidase (ChoE) is not important in the virulence of Rhodococcus equi. Vet. Microbiol. 2006, 118:240-246.
19. Prescott J.F., Hoffman A.M. Rhodococcus equi. Vet. Clin. North Am. Equine Pract. 1993, 9:375-384.
20. Schwab J.C., Mandell G.L. The importance of penetration of antimicrobial agents into cells. Infect. Dis. Clin. North Am. 1989, 3:461-467.
21. Takai S., Anzai T., Fujita Y., Akita O., Shoda M., Tsubaki S., Wada R. Pathogenicity of Rhodococcus equi expressing a virulence-associated 20kDa protein (VapB) in foals. Vet. Microbiol. 2000, 76:71-80.
22. Timmer A.M., Timmer J.C., Pence M.A., Hsu L.C., Ghochani M., Frey T.G., Karin M., Salvesen G.S., Nizet V. Streptolysin O promotes group A Streptococcus immune evasion by accelerated macrophage apoptosis. J. Biol. Chem. 2009, 284:862-871.
23. Toossi Z. Adjunctive immunotherapy of tuberculosis. Cytokines Cell. Mol. Ther. 1998, 4:105-112.
24. Wada R., Kamada M., Anzai T., Nakanishi A., Kanemaru T., Takai S., Tsubaki S. Pathogenicity and virulence of Rhodococcus equi in foals following intratracheal challenge. Vet. Microbiol. 1997, 56:301-312.
25. Wagner C., Sauermann R., Joukhadar C. Principles of antibiotic penetration into abscess fluid. Pharmacology 2006, 78:1-10.
26. Walev I., Bhakdi S.C., Hofmann F., Djonder N., Valeva A., Aktories K., Bhakdi S. Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:3185-3190.
27. Welsh K.J., Hwang S.A., Hunter R.L., Kruzel M.L., Actor J.K. Lactoferrin modulation of mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response. Transl. Res. 2010, 156:207-215.
28. Womble A.Y., Giguere S., Lee E.A., Vickroy T.W. Pharmacokinetics of clarithromycin and concentrations in body fluids and bronchoalveolar cells of foals. Am. J. Vet. Res. 2006, 67:1681-1686.